Actinomycetes have the genetic capability to synthesize many different
biologically active secondary metabolites and of these compounds, ant
ibiotics predominate in therapeutic and commercial importance. Intensi
ve research often centres on the use of molecular techniques to invest
igate the physiology and genetics of antibiotic biosynthesis with a vi
ew to improving production. The isolation of clones of Streptomyces hy
groscopicus, the producer of geldanamycin, which synthesizes geldanamy
cin in S. lividans, is reported. Molecular approaches using genes for
elongation factors (tuf) were used in attempts to increase the ferment
ation yield of kirromycin, whilst probes for aphD and sph, genes for s
treptomycin phosphotransferases, were used to gather information on st
reptomycin genes in soil. Actinomycete populations in soil and earthwo
rms may help in developing a strategy for discovering additional antim
icrobials in soil. The relationship of proline metabolism to the secon
dary metabolite undecylprodigiosin and the carbon regulation of spiram
ycin biosynthesis in S. ambofaciens is also reported.